z-logo
open-access-imgOpen Access
Levosimendan for Hemodynamic Support after Cardiac Surgery
Author(s) -
Giovanni Landoni,
В. В. Ломиворотов,
Gabriele Alvaro,
Rosetta Lobreglio,
Antonio Pisano,
Fabio Guarracino,
Maria Grazia Calabrò,
E. V. Grigoryev,
В. В. Лихванцев,
Marcello Fonseca SalgadoFilho,
Alessandro Bianchi,
Vadim Pasyuga,
Massimo Baiocchi,
Federico Pappalardo,
Fabrizio Monaco,
Vladimir Boboshko,
Marat Abubakirov,
B Amantea,
Rosalba Lembo,
Luca Brazzi,
Luigi Verniero,
Pietro Bertini,
Anna Mara Scandroglio,
Tiziana Bove,
Alessandro Belletti,
Maria G. Michienzi,
Д. Л. Шукевич,
Tatiana S. Zabelina,
Rinaldo Bellomo,
Alberto Zangrillo
Publication year - 2017
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1616325
Subject(s) - levosimendan , medicine , placebo , intensive care unit , anesthesia , perioperative , cardiac surgery , hemodynamics , confidence interval , cardiac output , randomized controlled trial , cardiology , heart failure , alternative medicine , pathology
Acute left ventricular dysfunction is a major complication of cardiac surgery and is associated with increased mortality. Meta-analyses of small trials suggest that levosimendan may result in a higher rate of survival among patients undergoing cardiac surgery.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom